LIMAF (LIMAF) Stock Price & Analysis
LIMAF (LIMAF) fell 0.30% to USD 75.79 as of June 10, 2026 at 02:18 UTC, according to Nexqual real-time market data.
LIMAF last closed at USD 76.02; the session ranged USD 75.79–75.79 on volume of 300 shares. Market capitalization is $4.49B, with a 52-week range of USD 45.1–76.53 (PNK). Source: Nexqual, June 10, 2026 at 02:18 UTC.
Key Statistics (as of June 10, 2026 at 02:18 UTC)
| Price | USD 75.79 |
|---|---|
| Change | ▼ 0.30% (down) |
| Previous Close | USD 76.02 |
| Open | USD 75.79 |
| Day Range | USD 75.79 – 75.79 |
| 52-Week Range | USD 45.1 – 76.53 |
| Volume | 300 shares |
| Market Cap | $4.49B |
| Exchange | PNK |
Technical Analysis (LIMAF)
Nexqual's technical model rates LIMAF "BUY" based on 5 bullish and 2 bearish signals across 123 daily candles, as of June 10, 2026 at 02:18 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 73.84 (overbought) |
| vs SMA50 | Above (USD 66.45) |
| MACD | 2.55 (positive) |
Analyst Ratings (LIMAF)
Wall Street analysts rate LIMAF "None", per Nexqual as of June 10, 2026 at 02:18 UTC.
| Consensus Rating | None |
|---|
Earnings (LIMAF)
| Next Earnings Date | 2026-05-06 |
|---|---|
| Revenue Estimate | $3.06B |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Financials & Fundamentals (LIMAF)
| Total Revenue | $10.64B |
|---|---|
| Revenue Growth (YoY) | +5.50% |
| Gross Margin | +14.74% |
| Operating Margin | +9.13% |
| Profit Margin | +5.90% |
| ROE | +10.51% |
| Current Ratio | 1.5 |
| Free Cash Flow | $718.70M |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Financial Health Score (LIMAF)
Nexqual rates LIMAF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:18 UTC.
| Growth | Weak — Revenue -3% YoY (annual), declining |
|---|---|
| Profitability | Weak — Gross margin 15%, operating 9% |
| Balance Sheet | Mixed — No data |
| Cash Flow | Solid — FCF $719M, 7% margin |
| Efficiency | Mixed — ROE 11%, ROA 5.5% |
Ownership (LIMAF)
| Insider Ownership | +36.01% |
|---|---|
| Institutional Ownership | +22.38% |
| Shares Outstanding | 59.21M |
| Float | 37.80M |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Leadership (LIMAF)
LIMAF is led by Jim Jarrell (age 61), President, CEO & Director, per Nexqual as of June 10, 2026 at 02:18 UTC.
| President, CEO & Director | Jim Jarrell (age 61) |
|---|---|
| Executive Chairman of the Board | Linda S. Hasenfratz (age 59) |
| Group President of Linamar North America & Europe | Salvatore Cocca |
| Group President of Linamar Agriculture | Kurt Lawrence Buehler |
| CTO, Executive VP of Sales & Marketing and Non-Independent Director | Mark Stoddart (age 61) |
Major Backers & Investors (LIMAF)
Notable institutional backers of LIMAF include DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT., American Century ETF Trust-Avantis International Small Cap Value ETF, HEARTLAND GROUP INC.-Heartland Value Fund, according to Nexqual as of June 10, 2026 at 02:18 UTC.
Active Investors
| Investor | Stake |
|---|---|
| DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT. | 2.37% |
| American Century ETF Trust-Avantis International Small Cap Value ETF | 0.64% |
| HEARTLAND GROUP INC.-Heartland Value Fund | 0.24% |
| Charles Schwab | 0.18% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.82% |
| Dimensional Fund Advisors | 0.37% |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NNCHY | Nissan Chemical Corporation | USD 48.86 | ▲ 0% |
| 7872.T | ESTELLE HOLDINGS CO LTD | JPY 590 | ▼ 0.67% |
| QYM.DU | Soc.Quimica y Min.de Chile SA R | EUR 64 | ▲ 1.59% |
| 016250.KQ | SGC E&C | KRW 11,300 | ▼ 1.14% |
| 1777.TWO | SYN-TECH CHEM. & PHARM. CO | TWD 71.6 | ▼ 0.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:18 UTC. This page is informational and not investment advice.